Thailand Launches Medical Cannabis Hotline to Enhance Safe Use and Public Guidance
Thailand has opened a medical cannabis hotline to provide legal and medical guidance, facilitate complaints, and verify credentials, reflecting a proactive approach to regulating cannabis use
Key Points
- 1Thailand's Department of Thai Traditional and Alternative Medicine has launched a medical cannabis hotline and coordination centre
- 2The service offers legal and medical guidance, handles complaints, and verifies licences and certified personnel
- 3The hotline operates on weekdays from 8.30am to 4pm at 02-257-7042
- 4Officials say the initiative aims to promote safe and informed use of medical cannabis
Thailand has launched a new medical cannabis coordination centre and hotline, aiming to improve communication and ensure the safe use of cannabis for medical purposes. According to the Department of Thai Traditional and Alternative Medicine, this service will provide the public with reliable and accurate information about medical cannabis. Deputy director-general Tewan Thanirat explained that the initiative is designed to "provide accurate and reliable information on medical cannabis."
Dr Peeracha Kukasemkit, director of the Medical Cannabis Division, outlined the centre’s three main functions: offering basic legal and medical advice, acting as a complaint centre by coordinating with provincial public health offices, and verifying licences, prescribing doctors, and certified personnel. The hotline can be reached at 02-257-7042 during weekdays from 8.30am to 4pm, excluding public holidays. This move reflects Thailand's ongoing efforts to regulate cannabis use and provide clear guidance to both patients and healthcare providers
From the OG Lab newsroom perspective, the establishment of this hotline marks a significant step in standardizing medical cannabis practices in Thailand. By centralizing information and verification, authorities are addressing public concerns and building trust in the medical cannabis sector. This development could serve as a model for other countries considering similar regulatory frameworks for medical cannabis
